Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
ANTX
DERM
Add up to 3 more stocks
ANTX
AN2 Therapeutics, Inc.
-9.18%
$5.09-0.52Delayed quote: Oct 6, 2026, 2:34 PM EDT
Market Cap
$183.50M
52W Range
$1.00 - $7.19
DERM
Journey Medical Corporation
-5.75%
$6.30-0.39Delayed quote: Oct 6, 2026, 2:34 PM EDT
Market Cap
$173.52M
52W Range
$4.31 - $9.56
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 2.42 | 5.40 |
| P/S Ratio | N/A | 2.55 |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | 137.42 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 0.0% | 62.2% |
| Operating Margin | 0.0% | -13.2% |
| Net Margin | 0.0% | -8.9% |
| ROE | -47.8% | -19.0% |
| ROA | -44.4% | -6.2% |
| ROIC | -51.0% | -5.2% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 14.32 | 1.59 |
| Quick Ratio | 14.32 | 1.41 |
| Debt/Equity | 0.00 | 0.80 |
| Interest Coverage | N/A | -2.21 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.